Activity and Safety of Geptanolimab (GB226) for Patients with Unresectable, Recurrent, or Metastatic Alveolar Soft Part Sarcoma: A Phase II, Single-arm Study

Shi, YK; Cai, QQ; Jiang, Y; Huang, G; Bi, MH; Wang, BC; Zhou, YH; Wang, GW; Ying, HY; Tao, ZW; Shi, CM; Guo, Q; Gao, C

Shi, YK (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China.

CLINICAL CANCER RESEARCH, 2020; 26 (24): 6445

Abstract

Purpose: Patients with alveolar soft part sarcoma (ASPS) are rare and have few treatment options. We assessed the activity of geptanolimab (GB226), a ......

Full Text Link